Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood pressure reduction and cerebral perfusion in hypertensive elderly patients
NL-OMON33986Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of chlorthalidone, amlodipine and valsartan in hypertension (HTN), sponsored by Radboud University Medical Center. Primary endpoint: Total cerebral blood flow. Started Aug 2009; status: active, not recruiting.
02
Drugs
chlorthalidoneamlodipinevalsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NL-OMON33986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33986.